Chiesi launches rare diseases business unit

Credit: Shutterstock.com/ PowerUp

Italian pharmaceutical group, Chiesi, is establishing a rare diseases business unit to advance research and new product development for rare and ultra-rare diseases.

The Chiesi Global Rare Diseases unit will be headquartered in Boston, Massachusetts and will initially focus on research and product development in lysosomal storage disorders, rare haematology and ophthalmology disorders.

Giacomo Chiesi, Head of Chiesi Global Rare Diseases, said: “Chiesi has a long history of success in discovering, developing and commercialising innovative therapies to address unmet needs for people living with rare diseases.

“With the Chiesi Global Rare Diseases unit, we are taking this to an entirely new level – rededicating and strengthening our efforts to support individuals and families affected by rare diseases all around the world.”